CDXS
CDXS
NASDAQ · Life Sciences Tools & Services

Codexis Inc

$2.26
-0.07 (-3.00%)
As of Jun 30, 10:31 PM ET ·
Financial Highlights (FY 2026)
Revenue
69.41M
Net Income
-43,361,098
Gross Margin
86.7%
Profit Margin
-62.5%
Rev Growth
-20.2%
D/E Ratio
0.79
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 86.7% 86.7% 54.9% 54.9%
Operating Margin -59.3% -53.4% 15.1% 14.1%
Profit Margin -62.5% -59.4% 11.9% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 69.41M 87.00M 48.43M 53.29M
Gross Profit 60.20M 75.45M 26.58M 29.25M
Operating Income -41,158,335 -46,430,811 7.30M 7.53M
Net Income -43,361,098 -48,915,753 5.77M 5.06M
Gross Margin 86.7% 86.7% 54.9% 54.9%
Operating Margin -59.3% -53.4% 15.1% 14.1%
Profit Margin -62.5% -59.4% 11.9% 9.5%
Rev Growth -20.2% -20.2% +4.8% -3.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 45.25M 45.25M 36.68M 34.44M
Total Equity 57.01M 57.01M 50.40M 46.39M
D/E Ratio 0.79 0.79 0.73 0.74
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -36,134,248 -43,027,745 7.56M 9.74M
Free Cash Flow 6.31M 7.69M